 Antithrombin III
"Antithrombin III" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A plasma alpha 2 glycoprotein that accounts for the major antithrombin activity of normal plasma and also inhibits several other enzymes. It is a member of the serpin superfamily.
| Descriptor ID |
D000990
|
| MeSH Number(s) |
D12.644.822.750.060.500 D12.644.861.060.500 D12.776.124.790.106.125 D12.776.377.715.085.125 D12.776.645.750.060.500 D12.776.872.060.500 D23.113.025
|
| Concept/Terms |
Antithrombin III- Antithrombin III
- Serpin C1
- Heparin Cofactor I
- Cofactor I, Heparin
- Heparin Co-Factor I
- Heparin Co Factor I
AT III- AT III
- Baxter Brand of Antithrombin
- Antithrombin Baxter Brand
Thrombate III- Thrombate III
- Bayer Brand of Antithrombin
- Antithrombin Bayer Brand
Atenativ- Atenativ
- Pharmacia Brand of Antithrombin
- Antithrombin Pharmacia Brand
Kybernin- Kybernin
- Aventis Behring Brand of Antithrombin III
Antithrombin III-Alpha- Antithrombin III-Alpha
- Antithrombin III Alpha
- Antithrombin IIIAlpha
- Grifols Brand of Antithrombin
- Antithrombin Grifols Brand
|
Below are MeSH descriptors whose meaning is more general than "Antithrombin III".
Below are MeSH descriptors whose meaning is more specific than "Antithrombin III".
This graph shows the total number of publications written about "Antithrombin III" by people in this website by year, and whether "Antithrombin III" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1984 | 0 | 1 | 1 | | 1987 | 0 | 1 | 1 | | 1988 | 0 | 1 | 1 | | 1989 | 1 | 0 | 1 | | 2000 | 0 | 1 | 1 | | 2002 | 0 | 1 | 1 | | 2014 | 1 | 1 | 2 | | 2015 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Antithrombin III" by people in Profiles.
-
Niebler RA, Woods KJ, Murkowski K, Ghanayem NS, Hoffman G, Mitchell ME, Punzalan RC, Scott JP, Simpson P, Tweddell JS. A Pilot Study of Antithrombin Replacement Prior to Cardiopulmonary Bypass in Neonates. Artif Organs. 2016 Jan; 40(1):80-5.
-
Chiarella SE, Soberanes S, Urich D, Morales-Nebreda L, Nigdelioglu R, Green D, Young JB, Gonzalez A, Rosario C, Misharin AV, Ghio AJ, Wunderink RG, Donnelly HK, Radigan KA, Perlman H, Chandel NS, Budinger GR, Mutlu GM. ß2-Adrenergic agonists augment air pollution-induced IL-6 release and thrombosis. J Clin Invest. 2014 Jul; 124(7):2935-46.
-
Tosur Z, Green D, De Chavez PJ, Knutson KL, Goldberger JJ, Zee P, Liu K, Kim KY, Carnethon MR. The association between sleep characteristics and prothrombotic markers in a population-based sample: Chicago Area Sleep Study. Sleep Med. 2014 Aug; 15(8):973-8.
-
Byrnes JW, Swearingen CJ, Prodhan P, Fiser R, Dyamenahalli U. Antithrombin III supplementation on extracorporeal membrane oxygenation: impact on heparin dose and circuit life. ASAIO J. 2014 Jan-Feb; 60(1):57-62.
-
Straub A, Schiebold D, Wendel HP, Azevedo R, Dietz K, Ziemer G. Platelet anaesthesia during extracorporeal circulation: differential effects of GP IIb/IIIa blockers on platelet activation marker P-selectin expression at hypothermia. Thromb Res. 2008; 122(3):383-9.
-
Straub A, Wendel HP, Dietz K, Schiebold D, Peter K, Schoenwaelder SM, Ziemer G. Selective inhibition of the platelet phosphoinositide 3-kinase p110beta as promising new strategy for platelet protection during extracorporeal circulation. Thromb Haemost. 2008 Mar; 99(3):609-15.
-
Halstenberg S, Panitch A, Rizzi S, Hall H, Hubbell JA. Biologically engineered protein-graft-poly(ethylene glycol) hydrogels: a cell adhesive and plasmin-degradable biosynthetic material for tissue repair. Biomacromolecules. 2002 Jul-Aug; 3(4):710-23.
-
Weber N, Wendel HP, Ziemer G. Quality assessment of heparin coatings by their binding capacities of coagulation and complement enzymes. J Biomater Appl. 2000 Jul; 15(1):8-22.
-
Spaeny-Dekking EH, Kamp AM, Froelich CJ, Hack CE. Extracellular granzyme A, complexed to proteoglycans, is protected against inactivation by protease inhibitors. Blood. 2000 Feb 15; 95(4):1465-72.
-
Boudreaux MK, Weiss RC, Cox N, Spano JS. Evaluation of antithrombin-III activity as a coindicator of disseminated intravascular coagulation in cats with induced feline infectious peritonitis virus infection. Am J Vet Res. 1989 Nov; 50(11):1910-3.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|